H.R. 6517House116th Congress (2019-2021)In Committee

Stockpile Inventory Modernization Act of 2020

AI-Generated Summary

Updated April 14, 2026 at 11:52 AM UTC

The Stockpile Inventory Modernization Act of 2020 amends the Public Health Service Act to let the Secretary of Health and Human Services move drugs, vaccines, medical devices, and other supplies from the Strategic National Stockpile to any other federal department or agency. These transfers are done on a reimbursable basis and are limited to items that are within six months of expiration, can be replenished, and are deemed in the government's best interest. The bill also sets reporting requirements and a sunset date for the authority.

Key Provisions

Allows the Secretary to transfer stockpile items to any federal agency, provided the items are less than six months from expiry, can be restocked, and the transfer benefits the U.S. government.
Transfers are reimbursable; the Secretary can use the reimbursement without needing additional appropriations or being limited by fiscal year.
Requires the Secretary to report each transfer and the reimbursement amount to the House Energy and Commerce Committee and the Senate HELP Committee by September 30, 2022.
The authority to make these transfers expires on September 30, 2023.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action

HouseIntro Referral Latest Action

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

April 17, 2020

View full timeline

HouseIntro Referral

Introduced in House

April 17, 2020

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

April 17, 2020

Bill Text

Latest available legislative text

Reading Mode

Raw Text PDF XML

Introduced in HouseIssued April 17, 2020

116th CONGRESS

2d Session

H. R. 6517

IN THE HOUSE OF REPRESENTATIVES

April 17, 2020

Mrs. Brooks of Indiana (for herself and Ms. Eshoo) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Public Health Service Act to authorize the transfer to any Federal department or agency, on a reimbursable basis, any drugs, vaccines and other biological products, medical devices, and other supplies in the Strategic National Stockpile, and for other purposes.

Short title

This Act may be cited as the Stockpile Inventory Modernization Act of 2020.

Reimbursable transfers from Strategic National Stockpile

Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following:

(6)

Transfers and reimbursements

(A)

In general

Without regard to chapter 5 of title 40, United States Code, the Secretary may transfer to any Federal department or agency, on a reimbursable basis, any drugs, vaccines and other biological products, medical devices, and other supplies in the stockpile if—

(i)

the transferred supplies are less than six months from expiry;

(ii)

the stockpile is able to replenish the supplies, as appropriate; and

(iii)

the Secretary decides the transfer is in the best interest of the United States Government.

(B)

Use of reimbursement

Reimbursement derived from the transfer of supplies pursuant to subparagraph (A) may be used by the Secretary, without further appropriation and without fiscal year limitation, to carry out this section.

(C)

Report

Not later than September 30, 2022, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on each transfer made under this paragraph and the amount received by the Secretary in exchange for that transfer.

(D)

Sunset

The authority to make transfers under this paragraph shall cease to be effective on September 30, 2023.